Third Rock Ventures IV, L.P.'s Net Worth
$558 Million
Who is Third Rock Ventures IV, L.P.?
Third Rock Ventures IV, L.P. has an estimated net worth of $558 Million. This is based on reported shares across multiple companies, which include Fulcrum Therapeutics, Inc., Revolution Medicines, Inc., PLIANT THERAPEUTICS, INC., Tango Therapeutics, Inc., Relay Therapeutics, Inc., and Magenta Therapeutics, Inc..
SEC CIK
Third Rock Ventures IV, L.P.'s CIK is 0001688327
Past Insider Trading and Trends
2020 was Third Rock Ventures IV, L.P.'s most active year for acquiring shares with 7 total transactions. Third Rock Ventures IV, L.P.'s most active month to acquire stocks was the month of June. 2021 was Third Rock Ventures IV, L.P.'s most active year for disposing of shares, totalling 13 transactions. Third Rock Ventures IV, L.P.'s most active month to dispose stocks was the month of December. 2019 saw Third Rock Ventures IV, L.P. paying a total of $1,300,000.00 for 2,343,154 shares, this is the most they've acquired in one year. In 2021 Third Rock Ventures IV, L.P. cashed out on 6,872,394 shares for a total of $227,132,711.61, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PLIANT THERAPEUTICS, INC. (PLRX) Snapshot price: $16.11
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +2,750.00% | 7.69M |
—
|
—
| 7.97M |
Jun 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Relay Therapeutics, Inc. (RLAY) Snapshot price: $9.13
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -42.08% | -5.62M |
$40.40 | -$227,132,711.61 | 7.74M |
Jan 12 - Jan 14
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 12.8M |
—
|
—
| 12.8M |
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Fulcrum Therapeutics, Inc. (FULC) Snapshot price: $8.03
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.34M |
$16.00 |
—
| 2.34M |
Jul 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Revolution Medicines, Inc. (RVMD) Snapshot price: $29.84
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.42M |
—
|
—
| 1.42M |
Feb 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Tango Therapeutics, Inc. (TNGX) Snapshot price: $12.73
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.63% | -285.00K |
$9.95 | -$2,835,367.50 | 17.2M |
Aug 16 - Aug 19
| |||
Form 4
| -1.33% | -235.00K |
$9.86 | -$2,316,494.00 | 17.49M |
Jul 30 - Aug 1
| |||
Form 4
| -0.28% | -50.00K |
$9.84 | -$491,950.00 | 17.72M |
Jul 26
| |||
Form 4
| -1.66% | -300.60K |
$9.83 | -$2,955,931.29 | 17.77M |
Jul 24 - Jul 25
| |||
Form 4
| -2.10% | -387.74K |
$9.78 | -$3,793,446.41 | 18.07M |
Jul 22 - Jul 23
| |||
Form 4
| -1.03% | -191.49K |
$9.81 | -$1,878,478.60 | 18.46M |
Jul 18
| |||
Form 4
| -2.87% | -550.17K |
$9.79 | -$5,386,339.14 | 18.65M |
Jul 17
| |||
Form 4
| -0.84% | -162.50K |
$12.00 | -$1,950,000.00 | 19.2M |
Feb 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |